Pseudohypoparathyroidism historical perspective: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Historical Perspective== | ==Historical Perspective== | ||
*In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim. Pseudohypoparathyoroidism is the first hormone resistance syndrome to be discovered.<ref>{{cite journal |vauthors=Albright F, Burnett CH, Smith PH, Parson |date=1942 |title=Pseudohypoparathyroidism- An example of ‘Seabright-Bantam syndrome’ |url= |journal= Endocrinology |volume=30 |issue= |pages=922–32 |doi= |access-date= }}</ref> | |||
*In the same year, Albright hereditary osteodystrophy was clinically described together with pseudohypoparathyroidism. <ref name="pmid5002252">{{cite journal |vauthors=Eyre WG, Reed WB |title=Albright's hereditary osteodystrophy with cutaneous bone formation |journal=Arch Dermatol |volume=104 |issue=6 |pages=634–42 |year=1971 |pmid=5002252 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
Revision as of 19:03, 28 September 2017
|
Pseudohypoparathyroidism Microchapters |
|
Differentiating Pseudohypoparathyroidism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pseudohypoparathyroidism historical perspective On the Web |
|
American Roentgen Ray Society Images of Pseudohypoparathyroidism historical perspective |
|
Risk calculators and risk factors for Pseudohypoparathyroidism historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Historical Perspective
- In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim. Pseudohypoparathyoroidism is the first hormone resistance syndrome to be discovered.[1]
- In the same year, Albright hereditary osteodystrophy was clinically described together with pseudohypoparathyroidism. [2]